 We propose to follow a cohort of pregnant and post-partum Canadian women through the fall and winter of 20092010 and the anticipated second and third waves of the current pandemic in order to better understand the incidence, complications and risk factors for severe disease due to H1N1 influenza in pregnant women, and to contribute data on the safety and effectiveness of antivirals and vaccines in this population. 